Date: 2016-03-21
Type of information: Nomination
Compound: chief medical officer
Company: Autolus (UK)
Therapeutic area: Cancer - Oncology
Type agreement: nomination
Action mechanism:
Disease:
Details:
- • On March 21, 2016, Autolus announced that it has appointed Dr Vijay Peddareddigari as chief medical officer. Dr Peddareddigari started his career as a medical oncologist at MD Anderson Cancer Center before moving into the pharmaceutical industry where he initially served as Medical Director at GSK. He joins Autolus from Janssen Pharmaceuticals, where he served as Senior Director & Clinical Leader, Early Development. Until January 2016, he also held a position as Adjunct Assistant Professor of Medicine, Division of Haematology/Oncology at the University of Pennsylvania.
Financial terms:
Latest news:
Is general: Yes
